Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Atea Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −14 vs. Q2 2023
- Shares held
- 56.9M
- −193.8K (−0.3%) vs. Q2 2023
- Total value
- $170.6M
- −$42.7M (−20.0%) vs. Q2 2023
- New holders
- 6
- 44 more added
- Sold out
- 20
- 42 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 582,233 | $1.75M | 0.00% | +8,274+1.4% | Added |
| Citadel Advisors LLC | 584,688 | $1.75M | 0.00% | −897,095−60.5% | Reduced |
| Sectoral Asset Management Inc | 600,461 | $1.80M | 0.35% | +98,924+19.7% | Added |
| Vontobel Holding Ltd. | 600,461 | $1.80M | 0.02% | +98,924+19.7% | Added |
| Federated Hermes, Inc. | 608,786 | $1.83M | 0.00% | −5,204−0.8% | Reduced |
| Northern Trust Corp | 666,152 | $2.00M | 0.00% | +19,409+3.0% | Added |
| Acadian Asset Management LLC | 987,916 | $2.96M | 0.01% | −8,359−0.8% | Reduced |
| Tyrus Capital S.A.M. | 1,260,000 | $3.78M | 35.90% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,354,541 | $4.06M | 0.01% | −8,841−0.6% | Reduced |
| State Street Corp | 1,506,237 | $4.52M | 0.00% | −27,051−1.8% | Reduced |
| Stonepine Capital Management, LLC | 1,720,000 | $5.16M | 1.71% | +967,912+128.7% | Added |
| Geode Capital Management, LLC | 1,725,729 | $5.18M | 0.00% | +80,691+4.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7.46M | 0.83% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,600,000 | $10.8M | 1.52% | +573,545+19.0% | Added |
| Vanguard Group Inc | 4,573,440 | $13.7M | 0.00% | +55,841+1.2% | Added |
| BML Capital Management, LLC | 4,800,000 | $14.4M | 13.28% | +2,563,761+114.6% | Added |
| FMR LLC | 6,452,550 | $19.4M | 0.00% | −2,044,756−24.1% | Reduced |
| EcoR1 Capital, LLC | 6,995,861 | $21.0M | 0.72% | 00.0% | Unchanged |
| BlackRock Inc. | 8,191,502 | $24.6M | 0.00% | +482,789+6.3% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,547,181−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −203,566−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −101,587−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −97,107−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −84,030−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −90,068−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −56,460−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −33,674−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −28,882−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −10,113−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,911−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,521−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,015−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −426−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −83−100.0% | Sold out |